Development of avian influenza virus H5 DNA vaccine and MDP-1 gene of Mycobacterium bovis as genetic adjuvant

Genetic Vaccines and Therapy

Volumn 8, Issue , 2010, Pages

  Jalilian, Babak ^a   Omar, Abdul R ^a   Bejo, Mohd H ^a   Alitheen, Noorjahan B ^a   Rasoli, Mehdi ^a   Matsumoto, Sohkichi ^b  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AVIAN INFLUENZA VACCINE; COMPLEMENTARY DNA; DNA VACCINE; GENE PRODUCT; IMMUNOLOGICAL ADJUVANT; PROTEIN MDP1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL GENE; CHICKEN; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HEMAGGLUTINATION INHIBITION TEST; IMMUNIZATION; IMMUNOGENICITY; INFLUENZA VIRUS A H5N1; INOCULATION; MDP 1 GENE; MOLECULAR CLONING; MUSCLE; MYCOBACTERIUM BOVIS; NONHUMAN; RNA TRANSCRIPTION; SPLEEN;

AVIAN INFLUENZA VIRUS; GALLUS GALLUS; MYCOBACTERIUM BOVIS;

EID: 77952537538     PISSN: None     EISSN: 14790556     Source Type: Journal    
DOI: 10.1186/1479-0556-8-4     Document Type: Article

References (29)

1. Murphy BR, Webster RG. Orthomyxoviruses. In: Fields virology 1998, 1397-1445. Raven Press, New York.
2. Lewis DB. Avian flu to human influenza. Annual Review of Medicine 2006, 57:139-154. 10.1146/annurev.med.57.121304.131333, 16409141.
3. Voeten JTM, Brands R, Palache AM, Van Scharrenburg GJM, Rimmelzwaan GF, Osterhaus ADME, et al. Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium. Vaccine 1999, 17(15-16):1942-1950. 10.1016/S0264-410X(98)00464-2, 10217593.
4. Villarreal-Chavez C. Experience of the control of avian influenza in the Americas. Developments in Biologicals 2007, 130:53-60.
5. Govorkova EA, Webby RJ, Humberd J, Seiler JP, Webster RG. Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge. Journal of Infectious Diseases 2006, 194(2):159-167. 10.1086/505225, 16779721.
6. Kodihalli S, Kobasa DL, Webster RG. Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines. Vaccine 2000, 18(23):2592-2599. 10.1016/S0264-410X(99)00485-5, 10775793.
7. Crawford J, Wilkinson B, Vosnesensky A, Smith G, Garcia M, Stone H, et al. Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes. Vaccine 1999, 17(18):2265-2274. 10.1016/S0264-410X(98)00494-0, 10403594.
8. Vecino WH, Quanquin NM, Martinez-Sobrido L, Fernandez-Sesma A, Garci'a-Sastre A, Jacobs WR, et al. Mucosal immunization with attenuated Shigella flexneri harboring an influenza hemagglutinin DNA vaccine protects mice against a lethal influenza challenge. Virology 2004, 325(2):192-199. 10.1016/j.virol.2004.04.045, 15246259.
9. Chen Z, Matsuo K, Asanuma H, Takahashi H, Iwasaki T, Suzuki Y, et al. Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs. Vaccine 1999, 17(7-8):653-659. 10.1016/S0264-410X(98)00247-3, 10067670.
10. Hinkula J, Lundholm P, Wahren B. Nucleic acid vaccination with HIV regulatory genes: A combination of HIV-1 genes in separate plasmids induces strong immune responses. Vaccine 1997, 15(8):874-878. 10.1016/S0264-410X(96)00257-5, 9234537.
11. Leitner WW, Seguin MC, Ballou WR, Seitz JP, Schultz AM, Sheehy MJ, et al. Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites. Journal of Immunology 1997, 159(12):6112-6119.
12. Lima KM, Santos SA, Lima VMF, Coelho-Castelo AAM, Rodrigues JM, Silva CL. Single dose of a vaccine based on DNA encoding mycobacterial HSP65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis. Gene Therapy 2003, 10(8):678-685. 10.1038/sj.gt.3301908, 12692596.
13. Moraes MP, Mayr GA, Mason PW, Grubman MJ. Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24. Vaccine 2002, 20(11-12):1631-1639. 10.1016/S0264-410X(01)00483-2, 11858872.
14. Oveissi S, Omar AR, Yusoff K, Jahanshiri F, Hassan SS. DNA vaccine encoding avian influenza virus H5 and esat-6 of Mycobacterium tuberculosis improved antibody responses against AIV in chickens. Comparative Immunology, Microbiology and Infectious Diseases 2009,
15. Matsumoto S, Furugen M, Yukitake H, Yamada T. The gene encoding mycobacterial DNA-binding protein I (MDPI) transformed rapidly growing bacteria to slowly growing bacteria. FEMS Microbiology Letters 2000, 182(2):297-301. 10.1111/j.1574-6968.2000.tb08911.x, 10620682.
16. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H. A toll-like receptor recognizes bacterial DNA. Nature 2000, 408(6813):740-745. 10.1038/35047123, 11130078.
17. Prabhakar S, Annapurna PS, Jain NK, Dey AB, Tyagi JS, Prasad HK. Identification of an immunogenic histone like protein (HLP(mt)) of Mycobacterium tuberculosis. Tubercle and Lung Disease 1998, 79(1):43-53. 10.1054/tuld.1998.0004, 10645441.
18. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon γ gene-disrupted mice. Journal of Experimental Medicine 1993, 178(6):2243-2247. 10.1084/jem.178.6.2243, 2191280, 8245795.
19. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. Journal of Experimental Medicine 1993, 178(6):2249-2254. 10.1084/jem.178.6.2249, 2191274, 7504064.
20. Matsumoto S, Matsumoto M, Umemori K, Ozeki Y, Furugen M, Tatsuo T, et al. DNA augments antigenicity of mycobacterial DNA-binding protein 1 and confers protection against Mycobacterium tuberculosis infection in mice. Journal of Immunology 2005, 175(1):441-449.
21. Manoj S, Babiuk LA, Van Drunen Littel-van Den Hurk S. Approaches to enhance the efficacy of DNA vaccines. Critical Reviews in Clinical Laboratory Sciences 2004, 41(1):1-39. 10.1080/10408360490269251, 15077722.
22. Ferstl B, Zacher T, Lauer B, Blagitko-Dorfs N, Carl A, Wassmuth R. Allele-specific quantification of HLA-DQB1 gene expression by real-time reverse transcriptase-polymerase chain reaction. Genes and Immunity 2004, 5(5):405-416. 10.1038/sj.gene.6364108, 15175648.
23. Le Gall-Reculé G, Cherbonnel M, Pelotte N, Blanchard P, Morin Y, Jestin V. Importance of a prime-boost DNA/protein vaccination to protect chickens against low-pathogenic H7 avian influenza infection. Avian Diseases 2007, 51(SUPPL 1):490-494. 10.1637/7592-040206R.1, 17494616.
24. Lee C, Senne DA, Suarez DL. Development and application of reference antisera against 15 hemagglutinin subtypes of influenza virus by DNA vaccination of chickens. Clinical and Vaccine Immunology 2006, 13(3):395-402. 10.1128/CVI.13.3.395-402.2006, 1391955, 16522783.
25. Donnelly JJ, Friedman A, Ulmer JB, Liu MA. Further protection against antigenic drift of influenza virus in a ferret model by DNA vaccination. Vaccine 1997, 15(8):865-868. 10.1016/S0264-410X(96)00268-X, 9234535.
26. Toro H, Tang DC, Suarez DL, Zhang J, Shi Z. Protection of chickens against avian influenza with non-replicating adenovirus-vectored vaccine. Vaccine 2008, 26(21):2640-2646. 10.1016/j.vaccine.2008.02.056, 2720404, 18384919.
27. Bulbot M, Manvell RJ, Shell W, Brown IH. High level of protection induced by two fowlpox vector vaccines against a highly pathogenic avian influenza H5N1 challenge in specific-pathogen-free chickens. Avian Diseases 2010, 54(s1):257-261.
28. Kodihalli S, Goto H, Kobasa DL, Krauss S, Kawaoka Y, Webster RG. DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice. Journal of Virology 1999, 73(3):2094-2098. 104453, 9971791.
29. Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL. DNA vaccines: Protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proceedings of the National Academy of Sciences of the United States of America 1993, 90(24):11478-11482. 10.1073/pnas.90.24.11478, 48007, 8265577.